213 related articles for article (PubMed ID: 21560114)
21. Improved engraftment of human peripheral blood mononuclear cells in NOG MHC double knockout mice generated using CRISPR/Cas9.
Ka Y; Katano I; Nishinaka E; Welcker J; Mochizuki M; Kawai K; Goto M; Tomiyama K; Ogura T; Yamamoto T; Ito M; Ito R; Takahashi R
Immunol Lett; 2021 Jan; 229():55-61. PubMed ID: 33253759
[TBL] [Abstract][Full Text] [Related]
22. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
23. Characterization of 5C11-positive activated interferon-producing cells in patients with systemic lupus erythematosus.
Ohshima M; Kanda H; Kubo K; Yonezumi-Hayashi A; Tateishi S; Yamamoto K
Lupus; 2013 Jan; 22(1):44-51. PubMed ID: 23087259
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus.
Escalante A; Brey RL; Mitchell BD; Dreiner U
Am J Med; 1995 Jun; 98(6):559-65. PubMed ID: 7778571
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
26. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
Front Immunol; 2020; 11():1047. PubMed ID: 32625200
[TBL] [Abstract][Full Text] [Related]
27. Anti-phospholipid antibodies contribute to arteriosclerosis in patients with systemic lupus erythematosus through induction of tissue factor expression and cytokine production from peripheral blood mononuclear cells.
Motoki Y; Nojima J; Yanagihara M; Tsuneoka H; Matsui T; Yamamoto M; Ichihara K
Thromb Res; 2012 Oct; 130(4):667-73. PubMed ID: 22196362
[TBL] [Abstract][Full Text] [Related]
28. [Ocular manifestations in patients with systemic lupus erythematosus and antiphospholipid syndrome].
Ostanek L; Modrzejewska M; Bobrowska-Snarska D; Brzosko M
Pol Arch Med Wewn; 2007; 117 Suppl():18-23. PubMed ID: 18778014
[TBL] [Abstract][Full Text] [Related]
29. Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin.
Krause I; Blank M; Kopolovic J; Afek A; Goldberg I; Tomer Y; Shoenfeld Y
J Rheumatol; 1995 Jun; 22(6):1068-74. PubMed ID: 7545755
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Samarkos M; Davies KA; Gordon C; Loizou S
Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839
[TBL] [Abstract][Full Text] [Related]
31. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of miRNA associated with a disease-specific signature and secreted via extracellular vesicles of systemic lupus erythematosus patients suppresses target organ inflammation in a humanized mouse model.
Young NA; Schwarz E; Zeno BM; Bruckner S; Mesa RA; Jablonski K; Wu LC; Roberson EDO; Jarjour WN
Front Immunol; 2023; 14():1090177. PubMed ID: 38939646
[TBL] [Abstract][Full Text] [Related]
33. Human immunoglobulin production in immunodeficient mice: enhancement by immunosuppression of host and in vitro activation of human mononuclear cells.
Cavacini LA; Kennel M; Lally EV; Posner MR; Quinn A
Clin Exp Immunol; 1992 Oct; 90(1):135-40. PubMed ID: 1395094
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome.
Sthoeger ZM; Tartakovsky B; Bentwich Z; Mozes E
J Clin Immunol; 1993 Mar; 13(2):127-38. PubMed ID: 7686561
[TBL] [Abstract][Full Text] [Related]
35. Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives.
Idborg H; Zandian A; Sandberg AS; Nilsson B; Elvin K; Truedsson L; Sohrabian A; Rönnelid J; Mo J; Grosso G; Kvarnström M; Gunnarsson I; Lehtiö J; Nilsson P; Svenungsson E; Jakobsson PJ
Arthritis Res Ther; 2019 Feb; 21(1):62. PubMed ID: 30777133
[TBL] [Abstract][Full Text] [Related]
36. Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations.
Tektonidou MG; Petrovas CA; Ioannidis JP; Vlachoyiannopoulos PG; Moutsopoulos HM
Eur J Clin Invest; 2000 Jul; 30(7):646-52. PubMed ID: 10886305
[TBL] [Abstract][Full Text] [Related]
37. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
[TBL] [Abstract][Full Text] [Related]
38. A unique antiphospholipid assay recognizing phospholipid mixture compared with criteria antiphospholipid immunoassays in lupus patients.
Zuo Y; Willis R; Papalardo E; Petri M; Harris EN; Schleh A; DeCeulaer K; Smikle M; Vilá LM; Reveille JD; Alarcón GS; Gonzalez EB
Lupus; 2017 May; 26(6):606-615. PubMed ID: 27753626
[TBL] [Abstract][Full Text] [Related]
39. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
